Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Change in Accured Expenses of -$183.0 million for Q1 2026, down 402.75% year-over-year from $60.4 million in Q1 2025, and down 262.09% quarter-over-quarter from $112.9 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at -$183.0 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 402.75% year-over-year to -$183.0 million; the TTM figure through Mar 2026 stood at -$44.8 million (up 81.26% YoY), while the FY2025 annual figure was $101.8 million, up 131.61% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$183.0 million, down from $112.9 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $164.2 million in Q4 2023, with the low at -$183.0 million in Q1 2026.
- The 5-year median for Change in Accured Expenses is -$34.3 million (2023), against an average of -$20.9 million.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses sank 477.36% in 2023, then surged 223.67% in 2025.
- Zimmer Biomet Holdings' Change in Accured Expenses stood at $104.6 million in 2022, then surged by 56.98% to $164.2 million in 2023, then sank by 171.44% to -$117.3 million in 2024, then soared by 196.25% to $112.9 million in 2025, then sank by 262.09% to -$183.0 million in 2026.
- Business Quant data shows ZBH's Change in Accured Expenses at -$183.0 million in Q1 2026, $112.9 million in Q4 2025, and -$51.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn | 92.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.00 Mn |
| Jun 30, 2026 | 92.00 Mn |
| Mar 31, 2026 | -183.00 Mn |
| Mar 31, 2026 | -183.00 Mn |
| Dec 31, 2025 | 112.90 Mn |
| Dec 31, 2025 | 112.90 Mn |
| Sep 30, 2025 | -51.50 Mn |
| Sep 30, 2025 | -51.50 Mn |
| Jun 30, 2025 | 76.80 Mn |
| Jun 30, 2025 | 76.80 Mn |
| Mar 31, 2025 | -36.40 Mn |
| Mar 31, 2025 | -36.40 Mn |
| Dec 31, 2024 | -117.30 Mn |
| Dec 31, 2024 | -117.30 Mn |
| Sep 30, 2024 | -23.20 Mn |
| Sep 30, 2024 | -23.20 Mn |
| Jun 30, 2024 | -62.10 Mn |
| Jun 30, 2024 | -62.10 Mn |
| Mar 31, 2024 | -119.40 Mn |
| Mar 31, 2024 | -119.40 Mn |